---
schema_version: "secwatch.filing_event.v1"
accession: "0001635088-26-000095"
form_type: "8-K"
ticker: "ROIV"
cik: "0001635088"
company_name: "Roivant Sciences Ltd."
filed_at: "2026-09-18T11:14:32+00:00"
generated_at: "2026-09-18T11:15:08.248738+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Roivant AGM: directors re-elected, EY ratified, say-on-pay passes with ~54% support

## Summary
- Quorum of 652.1M shares (90.3% of 722.4M outstanding) present at Sept 16, 2026 AGM.
- Daniel Gold (375.8M for) and Meghan FitzGerald (422.4M for) re-elected as Class II directors.
- Ernst & Young ratified as FY2027 auditor with 651.3M votes for, 0.7M against.
- Non-binding say-on-pay approved: 316.7M for vs 269.1M against (53.9% of votes cast).

## SEC filing metadata
- accession: 0001635088-26-000095
- form_type: 8-K
- ticker: ROIV
- cik: 0001635088
- company_name: Roivant Sciences Ltd.
- filed_at: 2026-09-18T11:14:32+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635088/000163508826000095/0001635088-26-000095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635088/000163508826000095/roiv-20260916.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001635088-26-000095
- JSON: https://secwatch.observer/filing/0001635088-26-000095.json
- Plain text: https://secwatch.observer/filing/0001635088-26-000095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
